2023 Call for Presentations

Event Date: April 10-13, 2023
Location: Georgia World Congress Center in Atlanta, GA
Submission Deadline Date: Friday, August 12, 2022

The Rx Summit will notify applicants by the end of November 2022 regarding whether their submission was accepted or declined.

Please read before submitting a presentation proposal.

The Rx and Illicit Drug Summit is the largest national collaboration of professionals from local, state and federal agencies, business, academia, clinicians, treatment providers, counselors, educators, state and national leaders, law enforcement/ public safety, and advocates impacted by the opioid crisis.

The programs and presentations will be tailored to provide stakeholders timely and relevant information for their particular fields. Submissions will be reviewed by the Rx Summit’s National Advisory Board members, who represent multi-disciplinary interests.

Please be prepared to submit the following:

• Session/Poster title
• Abstract (max 250 words)
• Relevant evidence (max 250 words)
• Relevance to Rx Summit audience (max 150 words)
• Three (3) learning objectives
• Three (3) practical take-aways
• Identification of topic area (listed below)
• Presenter details to include profile information and conflict of interest documentation

The Rx Summit will be accepting presentation proposals that accommodate the following formats:

• Breakout Sessions (75-minutes, including a question and answer segment)
• Posters (which will be featured in the exhibit hall and have designated poster presentation times when presenters will be required to stand by their posters)

Please note the following limits:

• Limit of 4 presenters per breakout session, but 2 presenters are preferred. Per breakout session, up to 2 presenters are eligible for complimentary registration, complimentary hotel room, and travel reimbursement (see Rx Summit Presentation Terms and Conditions).
• Limit of 1 presenter per poster.
• Limit of 3 proposals per submitter.

All submission presenters will be required to agree to the Rx Summit Presentation Terms and Conditions before a proposal can be submitted.

Note: The Rx Summit National Advisory Board will accept presenter applications based on the following criteria:

Supporting evidence-based data from research or demonstrated results.

Intent to provide details on how to implement a successful program for others to replicate.

The Rx Summit National Advisory Board is seeking proposals that correspond to the following topic areas:

Advocacy ― Activities and programs developed by community organizations, faith and family groups, prevention and education networks, public health agencies (local, state, federal, etc.), or private organizations that support legislative, community, and family support programs.

Clinical ― Strategies that further the understanding of how to manage patients’ pain safely, address patients’ addiction issues, mitigate risks associated with Rx opioids, address health issues related to the opioid crisis (such as HIV and Hepatitis C infections), and set up clinical practices to respond to the opioid crisis, as well as the role of prescribing practices and pharmacies.

Illicit Drugs ― Statistical analysis of emerging threats, as well as new initiatives and proven strategies of policy, public health, and law enforcement tactics implemented in federal, state, and local responses to ever-changing drug use patterns, such as with heroin, fentanyl, and gabapentin, as well as stimulants.

Public Safety ― Innovative strategies by law enforcement, correctional institutions, judicial systems, and emergency medical services to enforce public protection effectively while also using their unique roles to improve prevention, management, and treatment of substance use disorder, with emphasis on stakeholder collaboration.

Prevention - Overdose ― Practical strategies and programs aimed at reducing the negative consequences associated with drug use, such as overdose prevention, supervised injection facilities, field-based drug testing, and syringe access.

Prevention - Primary ― Research and proven programs that seek to prevent initial substance use, including the study of drug trends and responses, alternative pain management strategies, crafting communication and social media campaigns, and the implementation of effective youth prevention programs, including peer-to-peer models.

Technology (PDMP & Data Surveillance) ― Systems and strategies that formulate and improve effective data gathering, sharing, and analysis through provider engagement and technology innovations.

Treatment & Recovery ― Successful, outcome-based treatment and recovery programs in response to the opioid epidemic, including the discussion of opportunities and challenges created by new federal laws, and treatment and recovery efforts for diverse populations, including veterans, older adults, etc.

Click here to download and review the Rx Summit Presentation Terms and Conditions.
Click here to download and review the Submission Guidelines.
Click here to download the Frequently Asked Questions.

Questions: Cindy Lackey at clackey@hmpglobal.com OR Michelle Hlavin at mhlavin@hmpglobal.com.